FDA Approved: PATADAY TWICE A DAY RELIEF — Supplemental Application (Alcon Laboratories, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Pataday Twice A Day Relief containing olopatadine hydrochloride, expanding its labeling for allergic conjunctivitis,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• PATADAY TWICE A DAY RELIEF (olopatadine hydrochloride)

Snippet

SUPPL AP for PATADAY TWICE A DAY RELIEF (OLOPATADINE HYDROCHLORIDE)